We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

44 hedge funds and large institutions have $18M invested in Lunai Bioworks in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

76% more capital invested

Capital invested by funds: $10.2M → $18M (+$7.79M)

38% more funds holding

Funds holding: 32 → 44 (+12)

0.02% more ownership

Funds ownership: 0.04% → 0.06% (+0.02%)

Holders
44
Holders Change
+12
Holders Change %
+37.5%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
10
Reduced
5
Closed
7
Calls
$124K
Puts
–
Net Calls
+$124K
Net Calls Change
-$7K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.19M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$959K
3
BlackRock
BlackRock
New York
+$871K
4
Renaissance Technologies
Renaissance Technologies
New York
+$820K
5
Millennium Management
Millennium Management
New York
+$585K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$1.71M
2
SM
Sabby Management
Florida
-$534K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$495K
4
DWA
Dorsey Wright & Associates
California
-$53K
5
JCM
Jacobi Capital Management
Pennsylvania
-$45K

LNAI Hedge Fund Activity: Q4 2021 in Review

44 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2021, worth a combined $18M — up 76% from $10.2M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new LNAI positions and 7 closed out — a net gain of 12 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $6.19M. The largest seller was Invesco, exiting entirely with an estimated $1.71M sold.

  • 44 institutional investors held Lunai Bioworks (LNAI) as of Q4 2021, up from 32 in Q3 2021.
  • Funds reported $18M of Lunai Bioworks stock for Q4 2021, up 76% quarter-over-quarter.
  • 19 funds opened new Lunai Bioworks positions in Q4 2021 and 7 closed out, a net change of +12 holders.
  • The largest Lunai Bioworks buyer in Q4 2021 was Vanguard Group, an estimated $6.19M added.
  • The largest Lunai Bioworks seller in Q4 2021 was Invesco, an estimated $1.71M sold.

Based on aggregated 13F filings for Q4 2021.